compound or to its pharmaceutically acceptable salt, where R represents COOH or CH2OH. Invention also relates to pharmaceutical composition based on formula I, method of modulating CFTR activity in biological sample, based on application of formula I compound, method of treatment, based on application of formula I compound, set based on formula I compound.;EFFECT: obtained are novel derivatives of quinolin-4-one, useful as CFTR modulators.;18 cl, 1 tbl, 8 ex"/>
公开/公告号RU2518897C2
专利类型
公开/公告日2014-06-10
原文格式PDF
申请/专利号RU20110142297
发明设计人 JANG SJAOTSIN (US);ADIDA RUA SARA S. (US);GROTENKHEJS PETER D. J. (US);VAN GOR FREDRIK F (US);BOTFILD MARTIN K. (US);ZLOKARNIK GREGOR (US);
申请日2010-03-19
分类号C07D215/233;A61K31/47;A61P1/18;A61P11;A61P27;
国家 RU
入库时间 2022-08-21 15:38:28